Healthcare & Life Sciences

• Advise on pharmaceutical, medical device, healthcare, cosmetic, food and dietary food regulations

• Provide antitrust and compliance advice to domestic and multinational pharmaceutical companies, medical device companies and medical institutions

• Advise on alcohol and tobacco regulations

• Advise on drug and medical device pricing & reimbursement under the National Health Insurance system

• Advise on clinical trial related matters

• Advise on corporate transactions of pharmaceutical and medical device industries including:

• - Bayer’s Mercilon business transfer to Alvogen Korea

• - Lotus Pharma’s equity investment in Alvogen Korea

• - Baxter’s spin-off of Baxalta business

• - Shire and Baxalta merger transaction

• - Johnson & Johnson’s acquisition of Pfizer’s consumer healthcare business

• - 3M’s sale of its pharmaceutical business in Korea

• - Celltrion’s acquisition of Hanskin

Corporate

• Advised LS Cable & System Asia on the sale of its stake to investors

• Advised SeAH Steel on tis spin-off of sheet metal business

• Advised SeAH Network on its sale of Dremline to an investor

• Advised Dongwon F&B on its acquisition of a meat processing company

• Advised Sehkoy Semiconductor New Material on its acquisition of UP Chemical

• Advised Bodyfriend on the sale of its stake to investors

• Advised LG Household and Health Care on its acquisition of Diamond spring water

• Advised WPP Group on its acquisition of Korean advertising companies including OSO, Pharmax and Digital Ocean

• Advised CJ on its sale of household business

Fair Trade

• Represent clients in Korea Fair Trade Commission’s investigations into pharmaceutical and medical devices industry

• Represent clients in reverse payment cases

• Represent a client in mobile phone handset collusion investigation

• Represent a client in hotel collusion case

• Represent a client in ramen collusion case

Education

• Advise on establishment foreign educational institution in Korea

• Advise on structural reform of universities in Korea

• Digital Health (International Comparative Legal Guides): Korea Chapter (Co-author, 2023-24)
• Pharma & Medical Device Regulation (Lexology GTDT): Korea Chapter (Co-author, 2022-24)
• The Healthcare Law Review: Korea Chapter (Co-author, 2022-24)
• “국가별 대학 설립 기준 분석에 따른 외국교육기관 설립 심사 기준에 관한 연구” (공동연구원, 2020, 한국연구재단 정책연구 용역과제)
• Distribution and Marketing of Drugs (Korea Chapter): A Global Guide From Practical Law (2018, 2015, Thomson Reuters)
• Practical Law Multi-Jurisdictional Guide: Life Sciences (Korea Chapter, 2012-2015)
• “대학구조개혁 촉진을 위한 출구전략과 업무 매뉴얼” (공동연구원, 2016, 교육부 정책과제)
• “학교법인 운영권 양수도” (연구책임자, 2014, 고려대학교 고등교육정책연구소)
• “의료광고와 영리목적의 환자 소개, 알선, 유인행위” (2012, 법률신문)
• The International Comparative Legal Guide to Pharmaceutical Advertising (Korea Chapter, 2009)
• “의료기기 인허가 및 의료현장에서의 사용”, 대한변호사협회 제439기 의료법 특별연수 (2024. 6.)
• “지적재산권 행사와 공정거래 (제약분야를 중심으로)”, 한국제약바이오협회, 윤리경영 워크숍 (2023. 11.)
• “임상시험과 컴플라이언스”, 한국글로벌의약산업협회/한국의료기기산업협회 공동세미나 (2022. 10.)
• “환자, 환자단체 대상 활동의 CP 이슈”, 한국제약바이오협회 2022 상반기 윤리경영 워크숍
• “제약산업 정부조사 동향 및 대응 전략”, 딜로이트 안진회계법인 제약산업 경영자 초청 조찬 세미나 (2018)
• “허용되는 경제적 이익 등에 관한 지출보고서”, 한국의료기기산업협회 공정경쟁규약 세미나 (2018)
• “청탁금지법 시행 1년 및 리베이트 수사 동향”, 한국의료기기산업협회 윤리위원회 정기워크숍 (2017)
• “계약 협상에 있어서의 주요 쟁점 사항 및 대응 방안”, 한국제약산업연구회 사업개발(BD) 실무 통합 과정 (2017)
• “제약기업 글로벌 협약의 이해”, 한국보건복지인력개발원 2017년 제약기업 해외진출 관리자 과정 (2017)
• “Transforming Risk into Value: 김영란법, 어떻게 대응할 것인가?”, Deloitte World Class Compliance Workshop (2016)
• “환자 및 환자단체와의 교류”, 제2회 제약산업 윤리경영 아카데미(한국제약협회, 한국다국적의약산업협회) (2015)
• 2015 KRPIA Ethical Business Practice Workshop (panelist) (2015)
• “제약기업 글로벌 협약의 이해”, 제1기 제약기업 관리자 전략과정, 한국보건복지인력개발원 (2015)
• “허가-특허 연계제도와 공정거래 이슈”, KFDC 법제학회 2015 춘계학술대회 (2015)
• “국내외 의료광고 규정의 이해”, 병원국제마케팅 전문과정, 한국보건복지인력개발원 (2014)
• “국제계약에서의 능동적 협상”, 글로벌 헬스케어 심화과정, 한국보건복지인력개발원 (2014)
• 2014 KRPIA Ethical Business Practice Committee Workshop (panelist) (2014)
• “허가-특허 연계제도와 공정거래법”(토론자), KFDC 법제학회 2014 춘계학술대회 (2014)
• “Business Partnership”, 한국신약개발연구조합 (2014)
• 2013 KRPIA Ethical Business Practice Committee Workshop (panelist) (2013)
• “M&A Transactions: Korean Pharmaceutical Industry”, 한국제약협회, 제약산업 발전을 위한 글로벌 제휴 및 인수합병 전략 컨퍼런스 (2013)
• “Business Partnership”, Multinational Company Business Development Assembly (2012)
• 2012 KRPIA Ethical Business Practice Committee Workshop (panelist) (2012)
• “제약산업과 공정거래법 집행”, 서울지방변호사회 공정거래 커뮤니티 (2011)
• 2011 KRPIA Code Workshop (panelist) (2011)
• In-House Counsel Forum, 의료관계법령의 개정과 컴플라이언스 (2010)
• 서울지방변호사협회 의무연수강좌, 부당고객유인행위의 주요쟁점 (제약산업을 중심으로) (2010)
• “Case Study on Drug Advertising”, KRPIA Ethical Business Practice Workshop (2006)